Individualizing cancer therapy. - Wikidata - wikimedia - TriplyDB

Individualizing cancer therapy.

Individualizing cancer therapy.

http://www.wikidata.org/entity/Q43005370

about

Individualizing cancer therapy.

http://www.wikidata.org/entity/Q43005370

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Individualizing cancer therapy.

@en

Individualizing cancer therapy.

@nl

type

label

Individualizing cancer therapy.

@en

Individualizing cancer therapy.

@nl

prefLabel

Individualizing cancer therapy.

@en

Individualizing cancer therapy.

@nl

P1433

Q43005370-9732FDA6-C27F-41E5-93E5-A5AD151F1831

P1476

Q43005370-DB1A67B4-8D70-4A5B-94ED-1A4882A6B20B

P2093

Q43005370-692FDCE1-B399-4FA4-B620-245F20F9E1EA

P2860

Q43005370-17947492-E3C8-44F7-99B2-B018192FD26A

Q43005370-695E9C30-13FB-4DDB-9C2E-577D014135B3

Q43005370-6CEA3E44-0570-434E-94F5-E0AFDE5FC3BE

Q43005370-9BB9F3C7-E7B8-44CB-B22A-39D225C19286

Q43005370-9C4DC08D-3ECC-4EC3-8146-9E93EA4279BB

Q43005370-A5D54276-C602-45E1-A85B-3AB45AB4E93E

Q43005370-A66C025F-979B-4190-A445-86CB76841A53

Q43005370-A9FB5CDD-3C6C-4FD8-AF29-7805B9F58935

Q43005370-BC7ED5C9-3C1B-4014-B516-9D09DF11ED6D

Q43005370-E6ACA711-E4B5-446B-A063-139C4C94BCBE

P304

Q43005370-82D023B1-10C2-4D92-8508-9DCA47584DBC

P31

Q43005370-A4550ABA-193C-4F27-98A6-9B71829F0B25

P356

Q43005370-4916FC98-D886-4D9E-ADD7-0421B474F071

P433

Q43005370-17911C18-A045-46D6-B4E5-F38C003A2ABE

P478

Q43005370-1C124B82-3BEB-4680-B079-EFC2B8AE0474

P50

Q43005370-30B6A5C8-5859-4D4A-AAFF-A7DE1F2EE892

P577

Q43005370-2FE0AC46-E211-40E4-ABCB-4F3D6E631B5B

P5875

Q43005370-6C577372-D1FF-4666-B6AB-527E3C679DE0

P698

Q43005370-A74F692E-C9CA-44EC-879F-796ABECE5A43

P356

10428194.2010.497125

P1433

Leukemia & Lymphoma

P1476

Individualizing cancer therapy.

@en

P2093

Tamar Tadmor

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.

Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha

Transcriptional regulation of the cyclin D1 gene at a glance.

Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review.

Pharmacogenetics of thiopurines in inflammatory bowel disease.

Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model.

Monitoring bortezomib therapy in multiple myeloma: screening of cyclin D1, D2, and D3 via reliable real-time polymerase chain reaction and association with clinico-pathological features and outcome.

MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer.

Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.

Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia.

P304

1585-1587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2010.497125

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44800820

http://www.w3.org/2001/XMLSchema#string

P698

20578822

http://www.w3.org/2001/XMLSchema#string